Langenberg & Company Analyst Recommendations & Stock Picks → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Langenberg & Company. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Langenberg & Company. Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrial Products Medical Miscellaneous Multi-Sector Conglomerates Oils/Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyCurrent PriceRating DateActionBrokerageAnalystRatingPrice TargetImpact on PriceDetailsActionsBABoeing$167.26+0.3%3/9/2022Initiated byLangenberg & Company-BuyLowView details for Langenberg & Company rating of Boeing (NYSE:BA) on 3/9/2022MMM3M$91.80+0.4%10/11/2021Upgraded byLangenberg & Company-Hold -> BuyLowView details for Langenberg & Company rating of 3M (NYSE:MMM) on 10/11/2021RTXRTX$101.40-0.3%5/3/2021Upgraded byLangenberg & Company-Hold -> BuyLowView details for Langenberg & Company rating of RTX (NYSE:RTX) on 5/3/2021CATCaterpillar$343.37+1.6%10/27/2020Downgraded byLangenberg & Company-Hold -> SellHighView details for Langenberg & Company rating of Caterpillar (NYSE:CAT) on 10/27/2020HONHoneywell International$193.45+0.2%5/1/2020Reiterated byLangenberg & CompanyAnalyst Brian LangenbergBuy$165.00MediumView details for Langenberg & Company rating of Honeywell International (NASDAQ:HON) on 5/1/2020MMM3M$91.80+0.4%4/9/2020Upgraded byLangenberg & CompanyAnalyst Brian LangenbergBuy$180.00N/AView details for Langenberg & Company rating of 3M (NYSE:MMM) on 4/9/2020 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. HONHoneywell International$193.45+0.2%4/9/2020Upgraded byLangenberg & CompanyAnalyst Brian LangenbergBuy$165.00N/AView details for Langenberg & Company rating of Honeywell International (NASDAQ:HON) on 4/9/2020AMEAMETEK$177.48-0.3%2/10/2020Downgraded byLangenberg & CompanyAnalyst Brian LangenbergHold$100.00MediumView details for Langenberg & Company rating of AMETEK (NYSE:AME) on 2/10/2020KOPNKopin$0.78-3.7%2/4/2019Initiated byLangenberg & Company-Buy$1.32HighView details for Langenberg & Company rating of Kopin (NASDAQ:KOPN) on 2/4/2019AVDLAvadel Pharmaceuticals$17.81-0.1%9/7/2017Reiterated byLangenberg & Company-Buy$27.00 -> $30.00LowView details for Langenberg & Company rating of Avadel Pharmaceuticals (NASDAQ:AVDL) on 9/7/2017OFIXOrthofix Medical$12.99-0.8%6/14/2017Reiterated byLangenberg & Company-Buy$53.25LowView details for Langenberg & Company rating of Orthofix Medical (NASDAQ:OFIX) on 6/14/2017OFSOFS Capital$9.46-2.8%3/27/2017Upgraded byLangenberg & Company-Hold -> Buy$16.00LowView details for Langenberg & Company rating of OFS Capital (NASDAQ:OFS) on 3/27/2017TGTXTG Therapeutics$13.47-3.2%3/7/2017Target Raised byLangenberg & Company-Positive$28.00 -> $30.00N/AView details for Langenberg & Company rating of TG Therapeutics (NASDAQ:TGTX) on 3/7/2017DOVDover$180.17+0.6%1/30/2017Upgraded byLangenberg & Company-Sell -> HoldN/AView details for Langenberg & Company rating of Dover (NYSE:DOV) on 1/30/2017CLRBCellectar Biosciences$3.03+0.3%12/21/2016Initiated byLangenberg & Company-Buy$270.00N/AView details for Langenberg & Company rating of Cellectar Biosciences (NASDAQ:CLRB) on 12/21/2016ROKRockwell Automation$280.17+1.2%4/28/2016Downgraded byLangenberg & Company-Buy -> HoldN/AView details for Langenberg & Company rating of Rockwell Automation (NYSE:ROK) on 4/28/2016MMM3M$91.80+0.4%12/24/2014Downgraded byLangenberg & Company-Buy -> Hold$170.00N/AView details for Langenberg & Company rating of 3M (NYSE:MMM) on 12/24/2014HONHoneywell International$193.45+0.2%1/27/2014Upgraded byLangenberg & Company-Hold -> Buy$90.00 -> $100.00N/AView details for Langenberg & Company rating of Honeywell International (NASDAQ:HON) on 1/27/2014TYGTortoise Energy Infrastructure$31.67-0.7%5/13/2013Downgraded byLangenberg & Company-NeutralN/AView details for Langenberg & Company rating of Tortoise Energy Infrastructure (NYSE:TYG) on 5/13/2013DHRDanaher$246.45+0.3%3/4/2013Reiterated byLangenberg & Company-Buy$62.00 -> $66.00N/AView details for Langenberg & Company rating of Danaher (NYSE:DHR) on 3/4/2013EMREmerson Electric$109.87+0.2%2/6/2013Downgraded byLangenberg & Company-Buy -> Hold$60.00N/AView details for Langenberg & Company rating of Emerson Electric (NYSE:EMR) on 2/6/2013HONHoneywell International$193.45+0.2%1/2/2013Downgraded byLangenberg & Company-Buy -> Hold$66.00N/AView details for Langenberg & Company rating of Honeywell International (NASDAQ:HON) on 1/2/2013SPXCSPX Technologies$121.52+1.4%1/2/2013Downgraded byLangenberg & Company-Buy -> Hold$75.00N/AView details for Langenberg & Company rating of SPX Technologies (NYSE:SPXC) on 1/2/2013ROKRockwell Automation$280.17+1.2%1/2/2013Downgraded byLangenberg & Company-Buy -> Hold$85.00N/AView details for Langenberg & Company rating of Rockwell Automation (NYSE:ROK) on 1/2/2013LNTAlliant Energy$49.59-1.3%11/16/2012Upgraded byLangenberg & Company-BuyN/AView details for Langenberg & Company rating of Alliant Energy (NASDAQ:LNT) on 11/16/2012PFLTPennantPark Floating Rate Capital$11.51+0.8%10/4/2012Initiated byLangenberg & Company-BuyN/AView details for Langenberg & Company rating of PennantPark Floating Rate Capital (NASDAQ:PFLT) on 10/4/2012MMM3M$91.80+0.4%9/17/2012Reiterated byLangenberg & Company-Hold$100.00N/AView details for Langenberg & Company rating of 3M (NYSE:MMM) on 9/17/2012HONHoneywell International$193.45+0.2%9/17/2012Reiterated byLangenberg & Company-Buy$66.00N/AView details for Langenberg & Company rating of Honeywell International (NASDAQ:HON) on 9/17/2012DHRDanaher$246.45+0.3%9/17/2012Reiterated byLangenberg & Company-Buy$62.00N/AView details for Langenberg & Company rating of Danaher (NYSE:DHR) on 9/17/2012ROKRockwell Automation$280.17+1.2%9/17/2012Reiterated byLangenberg & Company-Buy$85.00N/AView details for Langenberg & Company rating of Rockwell Automation (NYSE:ROK) on 9/17/2012EMREmerson Electric$109.87+0.2%9/17/2012Reiterated byLangenberg & Company-Buy$60.00N/AView details for Langenberg & Company rating of Emerson Electric (NYSE:EMR) on 9/17/2012GEGeneral Electric$162.31+0.7%9/17/2012Reiterated byLangenberg & Company-Buy$240.00N/AView details for Langenberg & Company rating of General Electric (NYSE:GE) on 9/17/2012NYMTNew York Mortgage Trust$7.04+1.0%8/27/2012Initiated byLangenberg & Company-Hold -> BuyN/AView details for Langenberg & Company rating of New York Mortgage Trust (NASDAQ:NYMT) on 8/27/2012MMM3M$91.80+0.4%7/27/2012Downgraded byLangenberg & Company-Buy -> HoldN/AView details for Langenberg & Company rating of 3M (NYSE:MMM) on 7/27/2012 MarketBeat Community Rating for Langenberg & CompanyCommunity Ranking: 2.7 out of 5 (2.7 of 5 stars)Outperform Votes: 24,231 (Vote Outperform)Underperform Votes: 20,958 (Vote Underperform)Total Votes: 45,189MarketBeat's community ratings are surveys of what our community members think about Langenberg & Company and other research firms. Vote "Outperform" if you believe Langenberg & Company's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Langenberg & Company's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Ratings Reports and Tools Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Company Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Ratings for Popular Stocks: Alphabet (Google) Amazon Apple Meta (Facebook) Microsoft Netflix Nvidia Tesla Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
